AINOS INC (AIMD)
NASDAQInformation TechnologyBiotechnologySnapshot 2026-11-04
$0.63-14.01%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · AIMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 0.0 | 0.1 | 0.0 | 0.1 | 3.5 | 0.6 | 0.0 | 0.0 | 0.1 | 0.3 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Total Revenues | 0.0 | 0.1 | 0.0 | 0.1 | 3.5 | 0.6 | 0.0 | 0.0 | 0.1 | 0.3 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Cost of Revenues | 0.0 | 0.0 | 0.1 | 0.4 | 2.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | — | — | — | 0.0 | 0.0 | 0.0 |
| Gross Profit | 0.0 | 0.1 | (0.0) | (0.3) | 1.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.2 | — | — | — | 0.0 | 0.0 | 0.1 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 6.1 | 6.3 | 5.4 | 5.6 | 8.5 | 2.4 | 1.4 | 1.5 | 1.3 | 0.8 | 0.7 | — | — | 0.4 | 0.4 | 0.9 |
| R&D Expenses | 7.7 | 7.7 | 8.4 | 7.3 | 6.8 | 1.9 | 0.0 | 0.1 | 0.0 | — | — | — | — | 0.1 | 0.2 | 0.3 |
| Operating Income | (13.8) | (14.0) | (13.8) | (13.2) | (14.0) | (3.9) | (1.4) | (1.6) | (1.3) | (0.6) | (0.7) | — | — | (0.6) | (0.6) | (1.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.7 | 0.6 | 0.1 | 0.1 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | — | — | 0.1 | 0.2 | 0.2 |
| Other Non-Operating Income / Expenses | (0.7) | (0.8) | (1.0) | (0.6) | (0.0) | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (14.5) | (14.8) | (14.9) | (13.8) | — | (0.0) | (0.0) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | — | — | — | 0.0 | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (14.5) | (14.8) | (14.9) | (13.8) | (14.0) | (3.9) | (1.5) | (1.6) | (1.3) | (0.6) | (0.7) | — | — | (0.6) | (0.7) | (1.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (1.96) | (3.46) | (1.56) | — | — | — | — | — | — | — | — | — | — | — | — | (0.02) |
| Diluted EPS | (1.96) | (3.46) | (1.56) | — | — | — | — | — | — | — | — | — | — | (0.01) | (0.01) | (0.02) |
| Revenue per Share | 0.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 7.4 | 4.3 | 9.5 | — | — | — | — | — | — | — | — | — | — | — | — | 65.0 |
| Diluted Weighted Avg Shares | 7.4 | 4.3 | 9.5 | — | — | — | — | — | — | — | — | — | — | 73.4 | 73.4 | 65.0 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (9.2) | (9.0) | (8.3) | (9.1) | — | (1.4) | (1.6) | (1.3) | (0.5) | (0.6) | — | — | (0.6) | (0.5) | (1.1) |
| EBIT | (13.8) | (14.0) | (13.8) | (13.2) | (14.0) | (3.9) | (1.4) | (1.6) | (1.3) | (0.6) | (0.7) | — | — | (0.6) | (0.6) | (1.1) |
| Effective Tax Rate | — | — | — | — | — | — | 0.0% | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.